ALXN

Alexion Pharmaceuticals, Inc.
Exchange: Nasdaq
Develops and researches proprietary immunoregulatory compounds for treatment of autoimmune and cardiovascular, autoimmune and neurologic diseases caused by undesired effects of the human immune system.